Dr. M. Walid Qoronfleh is currently the Director of Healthcare Research and Policy at the World Innovation Summit for Health, Qatar Foundation, Doha, Qatar. Dr. Qoronfleh leads the WISH Doha-based research unit which is engaged in research areas that are of immediate global and local healthcare relevance to Qatar. The research is undertaken with a view to positively impacting health policy. These areas include autism, mental health, dementia, patient safety, non-communicable diseases (cancer, diabetes & obesity), precision medicine and bioethics. He has led, managed and/or contributed to various policy platforms (reports, case studies, panel discussion, etc.).
Immediately prior to WISH Walid was the Biotechnology Development Director at HBKU-QBRI in Qatar. Dr. Qoronfleh has over 20 years of scientific & technology (including research management & policy development), business, and commercial experience. He has held several senior management and executive positions with increasing responsibilities at GlaxoSmithKline, Sanofi, US_NIH-NCI, ThermoFisher, NextGen Sciences (VP, Personalized Medicine) and SDIX (Executive Director, Diagnostics business, Nasdaq: SDIX).
Dr. Qoronfleh is the founder of three biotechnology companies and he is a co-founder and the managing director of the boutique consulting company Q3CG. Dr. Qoronfleh has published over 100 combined peer reviewed abstracts and papers. He is also an editor and an ad hoc reviewer for various scientific journals plus a frequent speaker at national and international conferences. He holds degrees from The University of Louisville–School of Medicine (graduate medical), Penn State University (MBA), and The University of Wisconsin–Madison.